As of April 28, 2025, Lucid Diagnostics (LUCD) has a market cap of $0.14 billion USD. According to our data, Lucid Diagnostics is ranked No.7377 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 28, 2025 | $0.14 B |
181.20%
|
Dec 31, 2024 | $48.60 M |
-41.91%
|
Dec 29, 2023 | $83.67 M |
3.68%
|
Dec 30, 2022 | $80.71 M |
-74.67%
|
Dec 31, 2021 | $0.32 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Exact Sciences
EXAS
|
$8.58 B |
0.132 B
|
![]() USA
|
![]() Guardant Health
GH
|
$6.07 B |
0.107 B
|
![]() USA
|
![]() Natera
NTRA
|
$20.88 B |
93.349 M
|
![]() USA
|
![]() Fulgent Genetics
FLGT
|
$0.59 B |
6.807 M
|
![]() USA
|
![]() NeoGenomics
NEO
|
$1.30 B |
-0.019 B
|
![]() USA
|
![]() Adaptive Biotechnologies
ADPT
|
$1.18 B |
6.686 M
|
![]() USA
|
![]() Personalis
PSNL
|
$0.34 B |
-1.766 M
|
![]() USA
|
![]() Veracyte
VCYT
|
$2.54 B |
29.720 M
|
![]() USA
|
![]() Myriad Genetics
MYGN
|
$0.70 B |
17.973 M
|
![]() USA
|
![]() QuidelOrtho
QDEL
|
$1.93 B |
37.774 M
|
![]() USA
|
![]() Hologic
HOLX
|
$13.10 B |
-0.000 M
|
![]() USA
|
![]() Illumina
ILMN
|
$12.28 B |
41.151 M
|
![]() USA
|
Market Cap | = | LUCD Stock Price | * | LUCD Shares Outstanding |
= | $1.30 | * | 0.11 B | |
= | $0.14 B |